GCNT1 activators constitute a diverse array of chemical compounds that facilitate the enzymatic activity of GCNT1, a glycosyltransferase responsible for the biosynthesis of mucin-type O-glycans. The activation of GCNT1 is crucial in the extension and branching of these glycan structures, impacting various biological functions. Phorbol 12-myristate 13-acetate (PMA), by mimicking diacylglycerol, activates protein kinase C, which is known to regulate the activity of glycosyltransferases including GCNT1. The presence of essential cofactors such as Mn²⁺ ions, supplied by MnCl2, is paramount for the enzymatic function of GCNT1, enhancing its action by stabilizing the enzyme-substrate complex. Availability of substrates such as UDP-GlcNAc is directly proportional to GCNT1 activity, as this sugar nucleotide is incorporated into glycan structures by the enzyme. Similarly, the inhibition of competing glycosylation pathways by compounds like Tunicamycin may indirectly upregulate GCNT1 activity as a compensatory response, and inhibitors of O-glycanase, such as Benzyl-α-GalNAc, prevent the degradation of O-glycans, resulting in an increased substrate pool for GCNT1-mediated glycosylation.
Compounds like Swainsonine and Castanospermine, which inhibit glycosidase enzymes, lead to the accumulation of glycan precursors, potentially enhancing GCNT1 activity by providing it with more substrates. Brefeldin A, although primarily known for its disruption of Golgi structure, could indirectly enhance GCNT1 function as cells attempt to maintain glycosylation amid induced stress. The presence of galactose enhances the functional activity of GCNT1 by increasing the availability of activated UDP-galactose for glycan extension. Cobalt(II) chloride, like MnCl2, offers a cofactor that can support the functionality of GCNT1, albeit with less efficiency. Deoxynojirimycin contributes to the activation of GCNT1 by preserving intermediate glycan structures that are substrates for GCNT1. Collectively, these chemical activators orchestrate a conducive environment that enhances the glycosyltransferase activity of GCNT1, ensuring efficient glycan synthesis and processing without the need for upregulation of the protein's expression or direct stimulation of its catalytic activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog that activates protein kinase C (PKC). PKC has been implicated in the regulation of glycosyltransferases such as GCNT1. Through PKC activation, PMA can enhance the glycosylation process where GCNT1 activity is critical. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese (II) chloride provides Mn²⁺ ions, which are essential cofactors for many glycosyltransferases including GCNT1. The presence of Mn²⁺ at optimal concentrations enhances the enzymatic activity of GCNT1 by stabilizing the enzyme structure and facilitating substrate binding. | ||||||
N-Acetyl-D-glucosamine | 7512-17-6 | sc-286377 sc-286377B sc-286377A | 50 g 100 g 250 g | $94.00 $162.00 $306.00 | 1 | |
Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) is a direct substrate for GCNT1 during the glycosylation process. Availability of this sugar nucleotide is crucial for the enzymatic activity of GCNT1, thus its presence at sufficient levels ensures an enhanced functional activity of GCNT1. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, thereby potentially upregulating other glycosylation pathways including those catalyzed by GCNT1 as a compensatory mechanism. This can lead to enhanced GCNT1 activity to maintain glycan structures on proteins. | ||||||
Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside | 3554-93-6 | sc-203427 sc-203427A | 100 mg 1 g | $350.00 $3184.00 | 2 | |
This compound acts as an inhibitor of O-glycanase, leading to the accumulation of O-glycans that may serve as substrates for GCNT1, indirectly enhancing the activity of GCNT1 in extending O-glycan structures. | ||||||
D-Galactose | 59-23-4 | sc-202564 | 100 g | $288.00 | 4 | |
As a monosaccharide, galactose is a constituent of the glycosylation processes. Exogenous galactose can be activated within the cell to form UDP-Galactose, which can be utilized by GCNT1 to extend glycan structures, thereby enhancing its activity. | ||||||